SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-22-031350
Filing Date
2022-08-29
Accepted
2022-08-29 17:41:09
Documents
1
Period of Report
2022-08-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 5803
  Complete submission text file 0001140361-22-031350.txt   8165
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Issuer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NOGRA GROUP SICAF-SIF S.A. 18 AVENUE DE LA PORTE NEUVE LUXEMBOURG N4 L-2227
Business Address C/O NOGRA GROUP SICAF-SIF S.A. 18 AVENUE DE LA PORTE NEUVE LUXEMBOURG N4 L-2227 352 26200068
GG 1978 SICAF SIF S.A. - GG Strategic (Reporting) CIK: 0001814890 (see all company filings)

State of Incorp.: N4 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39329 | Film No.: 221212270

Mailing Address 18 AVENUE DE LA PORTE NEUVE LUXEMBOURG N4 L-2227
Business Address 18 AVENUE DE LA PORTE NEUVE LUXEMBOURG N4 L-2227 352 26200068
GG 1978 SICAF SIF S.A. (Reporting) CIK: 0001814891 (see all company filings)

State of Incorp.: N4 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39329 | Film No.: 221212269